where R1 comprises H or OAc and R2 comprises H or COCH(CH3)2; and a pharmaceutically acceptable carrier or salt, and the anti-hepatitis C composition is used for inhibiting hepatitis C virus or treating hepatitis C. The invention also provides a method for preparing a drug for inhibiting hepatitis C viruses or treating hepatitis C."/>
公开/公告号EP2263676A1
专利类型
公开/公告日2010-12-22
原文格式PDF
申请/专利号EP20100153974
申请日2010-02-18
分类号A61K31/58;A61P31/12;
国家 EP
入库时间 2022-08-21 17:56:17